Greg Barton

2.6k total citations
10 papers, 125 citations indexed

About

Greg Barton is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Greg Barton has authored 10 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Geriatrics and Gerontology. Recurrent topics in Greg Barton's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Greg Barton is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Greg Barton collaborates with scholars based in United Kingdom, Australia and France. Greg Barton's co-authors include Snehal Shah, Andréas Fischer, Mark Borthwick, Richard S Bourne, Cathrine McKenzie, Jeffrey Lipman, Jason A. Roberts, Claire Roger, Menino Osbert Cotta and Despoina Koulenti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Human Resources for Health.

In The Last Decade

Greg Barton

9 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Barton United Kingdom 5 77 34 26 20 17 10 125
Kevin D. Betthauser United States 10 72 0.9× 113 3.3× 35 1.3× 59 3.0× 11 0.6× 34 300
T. Fraisse France 9 67 0.9× 93 2.7× 47 1.8× 24 1.2× 12 0.7× 27 239
Juliano Gasparetto Brazil 9 52 0.7× 45 1.3× 82 3.2× 40 2.0× 8 0.5× 21 181
Christel Johanson Canada 8 116 1.5× 53 1.6× 23 0.9× 64 3.2× 14 0.8× 9 337
S. Hudson United Kingdom 8 21 0.3× 27 0.8× 15 0.6× 34 1.7× 31 1.8× 21 207
Sara E. Parli United States 10 39 0.5× 49 1.4× 16 0.6× 6 0.3× 32 1.9× 20 285
Mohamed Saad Qatar 9 42 0.5× 31 0.9× 10 0.4× 5 0.3× 28 1.6× 51 242
Ilse M. Purmer Netherlands 7 98 1.3× 97 2.9× 47 1.8× 36 1.8× 3 0.2× 12 282
Michael A. Veltri United States 11 41 0.5× 21 0.6× 27 1.0× 12 0.6× 48 2.8× 15 300
Dipu T Sathyapalan India 10 28 0.4× 73 2.1× 45 1.7× 33 1.6× 11 0.6× 43 315

Countries citing papers authored by Greg Barton

Since Specialization
Citations

This map shows the geographic impact of Greg Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Barton more than expected).

Fields of papers citing papers by Greg Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Barton. The network helps show where Greg Barton may publish in the future.

Co-authorship network of co-authors of Greg Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Barton. A scholar is included among the top collaborators of Greg Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Barton. Greg Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Borthwick, Mark, et al.. (2025). Stress ulcer prophylaxis practice in UK critical care units: A comparison of cross-sectional surveys between 2020 and 2024. Journal of the Intensive Care Society. 26(4). 466–471.
2.
Borthwick, Mark, et al.. (2023). Critical care pharmacy workforce: a 2020 re-evaluation of the UK deployment and characteristics. Human Resources for Health. 21(1). 28–28. 4 indexed citations
3.
Roger, Claire, Benjamin Louart, Loubna Elotmani, et al.. (2021). An international survey on aminoglycoside practices in critically ill patients: the AMINO III study. Annals of Intensive Care. 11(1). 49–49. 21 indexed citations
4.
Harrison, William, et al.. (2021). Fever in a patient with osteomyelitis: the diagnosis could be serotonin syndrome. BMJ Case Reports. 14(2). e239152–e239152. 4 indexed citations
5.
Borthwick, Mark, Greg Barton, Richard S Bourne, & Cathrine McKenzie. (2017). Critical care pharmacy workforce: UK deployment and characteristics in 2015. International Journal of Pharmacy Practice. 26(4). 325–333. 12 indexed citations
6.
Warin, R. P., Richard S Bourne, Mark Borthwick, Greg Barton, & Ian Bates. (2016). Advanced Level Practice Education: UK Critical Care Pharmacists’ Opinions in 2015. SHILAP Revista de lepidopterología. 4(1). 6–6. 4 indexed citations
7.
Barton, Greg, et al.. (2016). Infusion medication concentrations in UK’s critical care areas: Are the Intensive Care Society’s recommendations being used?. Journal of the Intensive Care Society. 18(1). 30–35. 9 indexed citations
8.
Tabah, Alexis, Jan J. De Waele, Jeffrey Lipman, et al.. (2015). The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs. Journal of Antimicrobial Chemotherapy. 70(9). 2671–2677. 9 indexed citations
9.
Shah, Snehal, Greg Barton, & Andréas Fischer. (2015). Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient. Journal of the Intensive Care Society. 16(2). 147–153. 61 indexed citations
10.
Barton, Greg, et al.. (2011). Introducing the accufuser: a new solution for ambulatory continuous epidural infusion. BMJ Supportive & Palliative Care. 1(2). 270.3–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026